Purine-rich foods

Community screening in Kelurahan Kereng Bangkirai using GCU testing with blood lancet and uric acid strips found that 41.9% (13 of 31 respondents) had elevated uric acid levels, while 58.1% (18 respondents) had normal levels. The screening concluded that dietary control of foods that increase uric acid is essential for those at risk of gout. High uric acid prevalence in the community underscores the importance of monitoring purine intake.

View Source →

This systematic review encompassing 315 subjects with spinal gout found that patient characteristics mirrored those of systemic gout, with 81% male predominance and mean age of 58.1 years. Publications documenting spinal gout cases have increased from 1950 to present, with cases reported from institutions in Asia (37.8%, n=119) and North America (30.5%, n=96). Pharmacological treatment was described for 34.2% of patients (n=108), while 46.3% required surgical intervention. The finding that spinal gout shares characteristics with systemic gout supports applying standard gout dietary management to potentially prevent this serious complication.

View Source →

In a community screening of 56 participants in Pondok Labu, Indonesia, 46 people (82.1%) who did not frequently consume high-purine foods demonstrated lower risk of gout arthritis. Among all participants, 24 people (42.9%) had elevated uric acid levels upon screening. The study identified consumption of high-purine foods as a key modifiable risk factor for gout arthritis development.

View Source →

Community screening study in Bandar Klippa, Percut Sei Tuan District (2022) identified dietary purine and xanthine intake as primary modifiable risk factors for elevated blood uric acid. The screening threshold of 6.8 mg/dl marks the solubility limit of uric acid in blood, above which crystallization occurs (hyperuricemia). Prolonged hyperuricemia progresses to gouty arthritis in a subset of affected individuals. The community education program targeted knowledge improvement about uric acid levels to reduce gout risk among participants who underwent blood uric acid testing.

View Source →

The NOR-Gout prospective cohort study involving 211 gout patients demonstrated that gout attacks may evolve after a purine-rich diet. With 88.2% follow-up completion at year 1 (n=186) and 82.0% at year 2 (n=173), the study population (mean age 56.4 years, 95.3% male, mean disease duration 7.8 years) showed that dietary purines remain a recognized trigger for flare occurrence in gout patients undergoing urate-lowering therapy.

View Source →

The 2020 ACR Gout Guideline, based on systematic review of available evidence and GRADE methodology, addresses dietary purine restriction as part of lifestyle management recommendations. The guideline panel included 8 male patients with gout who provided input on patient preferences and perspectives. Dietary modifications targeting purine intake are included among the 42 recommendations generated through the evidence-based consensus process.

View Source →

The British Society for Rheumatology guideline (Level of Evidence III, Strength of Recommendation 92%) recommends avoiding excessive intake of high purine foods as part of comprehensive dietary management for gout. This recommendation is integrated into a well-balanced diet approach that is low in fat and added sugars, high in vegetables and fibre, designed to help patients achieve and maintain serum uric acid targets below 300-360 μmol/L.

View Source →

This umbrella review analyzed 107 Mendelian randomisation studies covering 56 unique health outcomes. Only one outcome—gout—demonstrated convincing causal evidence linking high serum uric acid levels to increased disease risk (P<0.01). The Mendelian randomisation approach provides strong genetic evidence for causality, as it uses genetic variants as instrumental variables to assess the causal relationship between serum uric acid and health outcomes, minimizing confounding and reverse causation bias.

View Source →

A case-control study of 152 elderly participants (76 cases, 76 controls) in Puskesmas Tanjungsari Pacitan found a statistically significant correlation between purine intake and gout arthritis incidence (p<0.001). Cases were selected via simple random sampling, with controls matched from nearest neighbors. Chi-square analysis confirmed the association between dietary purine consumption and gout development in this East Java population where gout prevalence reaches 26.4% among elderly.

View Source →

The 3e initiative guideline was developed using formal voting processes with 78 international rheumatologists who conducted systematic literature reviews across multiple databases including Medline, Embase, and Cochrane CENTRAL. Studies were independently reviewed by two individuals for data extraction and risk of bias assessment. Dietary management including purine restriction was addressed within the six recommendations focusing on gout management. The multinational consensus from 14 countries achieved mean agreement scores of 8.7 out of 10, supporting dietary modification as part of comprehensive gout care.

View Source →

The Italian Society of Rheumatology clinical guideline, developed by a multidisciplinary panel including rheumatologists, nephrologists, cardiologists, and evidence-based medicine experts, adapted 12 EULAR propositions to the Italian context. The systematic review specifically collected further evidence about the role of diet in non-pharmacological treatment of gout. The guideline utilized EULAR ordinal and visual analogue scales to measure strength of recommendations, incorporating efficacy and safety data from RCTs combined in meta-analysis where feasible. Dietary intervention was identified as a priority research query through Delphi consensus among the expert panel.

View Source →

Case-control study of 196 participants (98 cases, 98 controls) in Masohi Town found purine food consumption had the highest odds ratio for gouty arthritis at OR = 5.14 (95% CI: 2.80-9.44). Multivariate logistic regression analysis confirmed purine food consumption as the most dominant factor affecting gout incidence (p = 0.000). The study concluded that dietary pattern modification is necessary for gout patients.

View Source →

The ACR guideline establishes that gout manifests from an excess body burden of uric acid, defined as serum urate above 6.8-7.0 mg/dl. The guideline recommends targeting serum urate below 6 mg/dl minimum, often 5 mg/dl, to achieve durable improvement in signs and symptoms. Patient education on diet and lifestyle is listed as a core therapeutic measure in gout management according to this clinical guideline developed with input from 22 expert panel members.

View Source →

A case-crossover study of 633 gout patients examined purine intake in the 2-day periods before gout attacks versus control periods. Compared to the lowest quintile of total purine intake, odds ratios for recurrent gout attacks increased progressively: 1.17, 1.38, 2.21, and 4.76 for each ascending quintile (p for trend <0.001). Animal-source purines showed stronger associations with ORs of 1.42, 1.34, 1.77, and 2.41 across quintiles (p for trend <0.001). Plant-source purines had a weaker association with ORs of 1.12, 0.99, 1.32, and 1.39 (p=0.04). The effect persisted regardless of sex, alcohol use, or medication status including allopurinol, NSAIDs, and colchicine use.

View Source →

The systematic review evaluated advice to reduce dietary intake of purines as a preventive intervention for gout recurrence. With 80% of gout patients experiencing recurrent attacks within 3 years, prevention strategies are critical. The review searched Medline, Embase, The Cochrane Library and other databases through June 2008, identifying 21 studies meeting inclusion criteria. GRADE evaluation was performed to assess evidence quality for purine restriction alongside other interventions including alcohol reduction and weight loss.

View Source →